roundhill glp-1 & weight loss etf | Invest in Weight Loss Stocks with OZEM Inside the GLP-1 Boom: ETF

Biotechnology companies invest heavily in research and development which may not necessarily lead to commercially successful products

We considered a subject as having been treated with GLP-1 M only if there were at least two different medication entries referring to GLP-1 M treatment in the subject record, and GLP-1 M treatment occurred together with or subsequent to ICD codes for T2D (10,517 subjects were selected using these rules)

2) We provide training, program and personal to assist church counselors

Acute Traumatic Amputation Presentation Complete or partial loss of limb/digit with visible separation or near-separation Massive hemorrhage or active bleeding at the amputation site Severe pain and neurovascular compromise distal to injury Avulsion with neurovascular bundle involvement Crush injury component (common in industrial and vehicular trauma) Shock (hemorrhagic) tachycardia, hypotension, pallor Postoperative / Chronic Amputation Status Signs Healed residual limb (stump) of variable length Phantom limb sensation or phantom limb pain Prosthesis use or fitting in progress Stump edema, skin breakdown, blistering Neuroma formation at the stump (palpable nodule, severe point tenderness) Heterotopic ossification at residual limb Amputation Stump Complications Stump infection: Erythema, warmth, purulence, fever, elevated WBC may involve superficial skin, deep soft tissue, or bone (osteomyelitis) Stump necrosis: Eschar formation, dark/black discoloration, malodor, failure of primary wound closure Wound dehiscence: Reopening of surgical closure Contact dermatitis/skin breakdown: Prosthetic socket irritation Chronic stump pain: Neuroma, bony spur, inadequate padding CDI Query Trigger When documentation mentions stump wound or wound care at residual limb, query the provider to clarify: Is this an infection (and if so, the causative organism), necrosis, or routine postoperative wound care

Investing in a weight loss ETF allows investors to hold a diversified portfolio of stocks from a range of companies involved in the sale and development of GLP-1-based obesity treatments

The following represent the primary codes relevant to amputation management, drawn from the CMS HCPCS 2026 code set